$132.86 meals Payment -- Takeda Pharmaceuticals to Dr. Jennifer Patel

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Takeda Pharmaceuticals made a $132.86 meals payment to Jennifer Patel, a Rare Disease specialist in Jacksonville, FL. A meal payment of $132.86 was made to Dr. Jennifer Patel by Takeda Pharmaceuticals on February 18, 2026. The payment was for 'Food and Beverage' and categorized as a 'meal'. This payment falls under the 'Rare Disease' specialty.

Patient Guidance: What This Payment Means for You

This record indicates a meal provided by a pharmaceutical company. It's important to understand how such interactions might influence medical advice. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Meal payments to physicians in the Rare Disease specialty are generally considered low value, but context regarding the frequency and nature of such payments is important.

Regulatory Context: Sunshine Act Requirements

Payments for meals are reportable under the Sunshine Act, provided they meet the reporting threshold and are not excluded by specific provisions.

Related Topics

This payment is related to the following healthcare transparency topics:

• meals
• food-and-beverage
• rare-disease
• takeda-pharmaceuticals
• jennifer-patel
• physician-payment

Understanding meals Payments

Food and beverage payments cover meals provided to physicians during pharmaceutical sales representative visits, medical conferences, and educational events. While individual meal payments tend to be small (often under $100), research published in JAMA Internal Medicine has shown that even modest meals can be associated with changes in prescribing behavior. Meal payments are the most common type of pharmaceutical payment to physicians.

Frequently Asked Questions About This Payment

What was this $132.86 payment for?

This was a meals payment of $132.86 from Takeda Pharmaceuticals to Jennifer Patel, categorized as "Food and Beverage". The payment was reported under the Sunshine Act (CMS Open Payments).

Does Jennifer Patel accept pharmaceutical money?

Yes, Jennifer Patel received this $132.86 payment from Takeda Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Jennifer Patel's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this meals payment?

A meals payment of $132.86 is generally routine and common in the industry. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Rare Disease?

To compare this payment against Rare Disease averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Rare Disease physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Jennifer Patel's relationship with Takeda Pharmaceuticals?

The payment was made in Jacksonville, FL. This $132.86 meals payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Rare Disease?

The payment ID is OP-MNIOITSY-INDN1Q.

What should patients do after learning about this payment?

This record indicates a meal provided by a pharmaceutical company. It's important to understand how such interactions might influence medical advice.

What else should I know about this meals payment?

Dr. Patel's NPI is 1187193173.

Related Reports

• View Dr. Jennifer Patel's full payment report
• Takeda Pharmaceuticals full spending report
• Browse all Rare Disease payments
• Browse all payments in Florida
• Search for other payments